India, June 16 -- D2C nutrition focused brand TruNativ has secured $30 Mn (Rs.290 Cr) in a Series B round from US-based investor OrbiMed. The round, which comprised both primary and secondary transactions, saw participation from TruNativ's existing investors including 100Unicorns, Rainmatter, Venture Catalysts, among others.

With the round, FMCG major Emami's stake in the startup has diluted to 10% from the 19% it acquired in 2022.

The startup will utilise the fresh capital to expand its offline retail presence in Tier I and II cities by partnering with leading supermarket chains as well as exploring partnerships to expand in the HORECA (hotel, restaurant, and catering) and D2C segments. It also plans to launch an innovation centre, "Th...